Tops & Flops Stocks
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 0.400% | -8.447% | -9.012% | 236.305% | 169.660% | 802.911% | - |
| Eli Lilly Corp. | 1.040% | -0.388% | 7.711% | 105.701% | 60.587% | 323.526% | 756.378% |
| Geron Corp. | 0.260% | 3.765% | -1.759% | 46.060% | 112.856% | 260.810% | 243.304% |
| Savara Inc. | - | 5.236% | 9.836% | 43.571% | -6.944% | 216.535% | 67.500% |
| Madrigal Pharmaceuticals inc. | -0.820% | 3.150% | 18.543% | 34.284% | 27.010% | 214.035% | 195.282% |
| Cytokinetics Inc. | -0.970% | 2.941% | 7.143% | 79.795% | -31.373% | 212.500% | - |
| Catalyst Pharmaceutical Partners Inc | -2.040% | -4.632% | -3.282% | 24.444% | -9.910% | 203.490% | 294.366% |
| Vertex Pharmaceuticals Inc. | 0.480% | 1.458% | -0.481% | 44.374% | 19.804% | 166.808% | 184.214% |
| Medpace Holdings Inc | 0.290% | -1.212% | 0.807% | 74.326% | 33.381% | 144.967% | - |
| Insmed Inc. | 13.160% | -7.317% | 9.615% | 216.667% | 99.301% | 143.590% | 159.091% |
| Sarepta Therapeutics | 0.750% | -4.144% | 22.548% | 40.795% | 58.171% | 127.339% | 4.394% |
| Voyager Therapeutics Inc | 1.460% | -1.775% | -7.756% | -23.048% | -9.497% | 121.657% | - |
| Ani Pharmaceuticals Inc. | -0.890% | -4.237% | -8.871% | 13.911% | 13.454% | 101.786% | -14.394% |
| Regeneron Pharmaceuticals Inc. | -0.860% | -1.219% | 4.739% | 53.983% | 21.931% | 100.495% | 262.093% |
| Intra-Cellular Therapies Inc. | -0.750% | 4.724% | 4.724% | 17.077% | 1.994% | 95.301% | 603.704% |
| United Therapeutics | 0.750% | -1.480% | 15.049% | 51.553% | 47.692% | 84.151% | 330.588% |
| Merck & Co. Inc. | -0.170% | -2.517% | -3.967% | 16.901% | 17.970% | 76.221% | 55.452% |
| Alnylam Pharmace. | 0.810% | 4.016% | 66.631% | 34.073% | 33.164% | 61.826% | 279.794% |
| Neurocrine Bioscience | 1.220% | 0.767% | 5.160% | 53.312% | 10.184% | 57.274% | 75.313% |
| AbbVie Inc. | -0.300% | -3.038% | -1.951% | 24.450% | 9.793% | 56.480% | 142.504% |